Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CG2001 Phase II Trial in Chinese Adult Men with Androgenetic Alopecia
CTR20244289Phase 2Completed
- Sponsor
- Chenguang Pharmaceutical
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CG2001 in androgenetic alopecia (AGA), sponsored by Chenguang Pharmaceutical. Started Nov 2024; status: completed.
02
Drugs
CG2001
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on CTR20244289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244289.